Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer

UnknownOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2019

Conditions
Pancreatic Neoplasms
Interventions
DIAGNOSTIC_TEST

Receptor specific activation method

NK cell was incubated with P815-ULBP1+CD48 cells that trigger NK cell synergy via NKG2D and 2B4

Trial Locations (1)

Unknown

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER

NCT03665571 - Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer | Biotech Hunter | Biotech Hunter